Everest submits IND in China for antibiotic

Tetraphase Pharmaceuticals Inc. (NASDAQ:TTPH) said C-Bridge-backed Everest Medicines Ltd. (Boston, Mass.) submitted an

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE